ASSERTIO THERAPEUTICS INC's ticker is and the CUSIP is 04545L907. A total of 4 filers reported holding ASSERTIO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $60,000 | -58.6% | 92,300 | -20.2% | 0.00% | -100.0% |
| Q4 2019 | $145,000 | +20.8% | 115,600 | +23.4% | 0.00% | 0.0% |
| Q3 2019 | $120,000 | -58.2% | 93,700 | +12.5% | 0.00% | -66.7% |
| Q2 2019 | $287,000 | -58.9% | 83,300 | -39.6% | 0.00% | -62.5% |
| Q1 2019 | $699,000 | -11.3% | 137,900 | -36.9% | 0.01% | +14.3% |
| Q4 2018 | $788,000 | -37.4% | 218,400 | +2.0% | 0.01% | -30.0% |
| Q3 2018 | $1,259,000 | – | 214,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GARGOYLE INVESTMENT ADVISOR L.L.C. | 12,500 | $43,000 | 0.05% |
| GROUP ONE TRADING, L.P. | 83,300 | $287,000 | 0.00% |
| SIMPLEX TRADING, LLC | 26 | $8,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |